GS vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Goldman Sachs Group, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
The Goldman Sachs Group, Inc. · Financial Services
$1,096.56
-45.0% upside to fair value
Grade C
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
GS trades at a lower forward P/E
(19.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GS |
TMO |
| Current Price |
$1,096.56 |
$464.61 |
| Fair Value Estimate |
$603.11 |
$498.27 |
| Upside to Fair Value |
-45.0%
|
+7.2%
|
| Market Cap |
$323.5B |
$172.7B |
| Forward P/E |
19.8x
|
25.2x
|
| EV / EBITDA |
42.8x
|
19.1x
|
| Price / Sales |
2.9x
|
3.8x
|
| Price / FCF |
-7.7x
|
25.6x
|
| Revenue Growth YoY |
-45.4%
|
+6.2%
|
| Gross Margin |
55.5%
|
39.4%
|
| Operating Margin |
20.5%
|
17.8%
|
| Return on Equity |
14.6%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
The Goldman Sachs Group, Inc. operates as a leading global financial services firm with a strong presence in investment banking, global markets, and asset and wealth management. The company benefits from a durable competitive moat based on scale, brand, client relationships, and technology infrastructure. However, recent financial data shows a significant 45.4% year-over-year revenue decline in t…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
GS |
TMO |
| Zone Low |
$452.33 |
$373.70 |
| Zone High |
$512.64 |
$423.53 |
| In Buy Zone? |
No
|
No
|